Janux Therapeutics, Inc.
JANX · NASDAQ
Bulios Fair Price
$11.73
31.4% downside
Trenutna cena
$17.1
Po podatkih Bulios Fair Price je delnica JANX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Janux Therapeutics is a biotechnology company focused on developing advanced therapeutic methods for cancer immunotherapy. The company specializes in utilizing its platform, which combines antibody technology with targeted therapeutic agents, to enhance the body's natural defense against cancer cells. Janux is developing various products, including bioconjugates, that aim to specifically target and destroy cancer cells while minimizing side effects on healthy tissues.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
David Alan Campbell
Employees
113
Headquarters
San Diego
Prihajajoči dogodki
Earnings
Upcoming earnings report